The Centers for Medicare & Medicaid Services Friday issued its calendar year 2023 proposed rule for the home health prospective payment system, which would reduce net HH payments by $810 million in calendar year 2023 relative to CY 2022. The rule also would strive to achieve budget-neutrality for the Patient-driven Groupings Model on a prospective basis through a 6.9 percentage point cut to all payments; and implement a 0.2% high-cost outlier cut. AHA said it was very concerned about the unprecedented scale of the proposed PDGM behavioral offset. In addition, the rule would require collection of all patient assessment data for the HH Quality Reporting Program; collect feedback on strategies to better measure disparities in health care outcomes; and change the terminology and timeline for baseline years used to calculate performance in the Value-based Purchasing program. CMS will accept comments on the proposed rule through Aug. 16. 

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on…
Headline
The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and…
Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…
Headline
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s…
Headline
Ashley Thompson, AHA senior vice president of public policy analysis and development, participated in a panel discussion during Modern Healthcare's Leadership…
Headline
The U.S. District Court for the District of Maine today issued an order denying preliminary injunctions requested by AbbVie and Novartis in legal challenges…